Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Video of David Hur discussing how to overcome technical challenges in cardiac CT, which he presented on in sessions at SCCT 2023.

Overcoming technical challenges in cardiac CT

David Hur, MD, director of structural heart disease/interventional imaging at the VA Connecticut Healthcare System, and an assistant professor of medicine at Yale, explains the technical challenges encountered in cardiac computed tomography (CT) and how to overcome them.

October 17, 2023
SentiAR CommandEP system

Technology that creates interactive holograms of the heart cleared by FDA

SentiAR's CommandEP interface facilitates 3D models of the heart, made possible through augmented reality. 

October 16, 2023
Robert Hendel, MD, Tulane University and former ASNC president, explains the pressing business aspects of nuclear cardiology and why ASNC included business management sessions at its 2023 annual meeting. #ASNC #ASNC23 #ASNC2023

Business considerations in the modern nuclear cardiology practice

Robert Hendel, MD, discussed everything from declining reimbursements in cardiology to prior authorization policies in an exclusive new interview. 

October 13, 2023
Timothy Bateman, MD, co-director, cardiovascular radiologic imaging program, Saint Luke's Mid America Heart Institute, professor of medicine at the University of Missouri-Kansas City School of Medicine, and an ASNC past-president, is one of the authors on the AURORA study. He spoke with Cardiovascular Business about the study and what it is like to work with flurpiridaz.

Flurpiridaz will have a major impact on cardiac PET and nuclear imaging

The new radiotracer flurpiridaz is poised to make a major impact on nuclear cardiology. Timothy Bateman, MD, co-director of the cardiovascular radiologic imaging program at Saint Luke's Mid America Heart Institute, shared details on the tracer in a new interview. 

October 10, 2023
GE HealthCare Venue Ultrasound System

GE HealthCare upgrades ultrasound systems with AI guidance

The Venue product line will receive a step-by-step guidance system designed to help even inexperienced operators capture quality cardiac images.

October 9, 2023
Mark Rabbat, MD, director of cardica CT at Loyola, discusses legislative advocacy efforts by SCCT to gain wider reimbursement for cardiac CT. #SCCT #SCCT23 #SCCT2023

SCCT hopes to increase cardiac CT reimbursements through advocacy

Mark Rabbat, MD, discusses the Society of Cardiovascular Computed Tomography's efforts to make an impact by lobbying in Washington. 

October 3, 2023
Video of ASNC President Mouaz Al-Mallah, MD, explaining some long-COVID cardiac symptoms might be due to coronary microvascular dysfunction. He was part of a recent study that used PET top assess myocardial perfusion that found there is impaired microvascular flow in long-COVID patients.

PET imaging helps assess coronary microvascular dysfunction in long COVID patients

Researchers noted that patients appeared to have myocarditis at first, but a closer examination revealed it was something else entirely. 

September 27, 2023
Video interview with Martha Gulati, MD, was the lead author of the 2021 chest pain guidelines and shares impacts.

Cardiac CT gaining popularity due to chest pain guidelines, cost savings

Cardiologist Martha Gulati, MD, lead author of the 2021 chest pain guidelines, explained how the document may have contributed to the rise of cardiac CT. "These guidelines have made it harder for people to push back and say you don't need this test," she said. 

September 20, 2023

Around the web

The newly approved AI models are designed to improve the detection of pulmonary embolisms and strokes in patients who undergo CT scans.

"I see, at least for the next decade, this being a SPECT and PET world, not one or the other," explained Tim Bateman, MD.

The FDA-approved technology developed by HeartFlow can predict a patient's long-term risk of target vessel failure as well as more invasive treatments performed inside a cath lab. 

Trimed Popup
Trimed Popup